
Keywords: 2-AG; 2-arachidonoylglycerol; 5-HT; 5-hydroxytryptamine anandamide N-arachidonoylethanolamide; BMS; burning mouth syndrome; CB; cannabinoid receptor; CBT; cognitive behavioural therapy; CNS; central nervous system; GABA; γ-Aminobutyric acid; HZ; herpes z